Furthermore, circCDYL (hsa_circ_0008285) was reported to augment autophagy of breast cancer cells via regulating the miR-1275-ATG7/ULK1 axis, which may be a potential biomarker for predicting the prognosis of breast cancer patients [218]. This evidence concerns the gene ULK1 and breast cancer.